PRMT3 and non-small cell lung carcinoma: Furthermore, our findings were corroborated by organoid cultures derived from tumor tissues of newly diagnosed patients with NSCLC, further supporting the role of PRMT3 in enhancing radiotherapy resistance (Fig. 1N).